GleamWall
中文EN

ALRTF ALR Technologies SG Ltd. Annual reports only

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1930419

Financial factors as of 2023-12-31 (FY2023), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY978.8%
TTM net income YoY29.6%
TTM EPS YoY50.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin13.5%
Operating margin—
Net margin-29,270.5%
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-2,807.4%
ROIC (approx.)—
Asset turnover0.10x

Leverage & solvency

Liabilities / assets20,664.8%
Debt / equity—
Current ratio—
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.22x
Accruals ratio-2,198.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue——
R&D expense$793,327$883,866
SG&A expense$1.47M$2.02M
Interest expense-$19.74M-$12.42M
Pretax income-$2.26M-$15.88M
Net income-$22.06M-$15.88M
EPS (basic)—-0.03
EPS (diluted)-0.04-0.03
Weighted avg. shares (diluted)606.99M598.92M
Banking
Net interest income$17.29M$9.82M
Balance sheet
Cash & equivalents$20,305$40,657
Inventory$10,843$10,863
Total assets$47,374$79,472
Total liabilities$39.91M$36.30M
Shareholders' equity-$39.86M-$36.22M
Cash flow statement
Operating cash flow-$1.87M-$1.54M
Financing cash flow$1.85M$1.52M
Stock-based compensation$17.29M$9.82M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.